Please login to the form below

Not currently logged in
Email:
Password:

Making the most of the NHS Information Revolution


The NHS is a source of rich data, including hospital episode statistics (HES), medicines prescriptions and GP performance measures (QOF), more and more of which is now becoming available in the public domain and at increasing levels of granularity. However, these are held in silos, in different formats, and so making the most of this massive opportunity is a real challenge for the pharmaceutical sector.

As a result of recent government data transparency initiatives, there has never been more of this NHS information publicly available, and even more detailed prescription data will be available later this year. But how can you turn these disparate data sources into valuable information that is quickly and cost-effectively available to help make critical business decisions?

Datapharm, a company with a well-established reputation with both the NHS and the pharmaceutical industry for turning complex data into user-friendly information, is pleased to offer you an invitation to a free webinar to explore how you can make the most of this data revolution. The webinar is produced in association with PMGroup.

Can't see the embedded webinar link below? Join the webinar on BrightTalk.


Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
nitrogen

nitrogen is a strategic brand experience agency which blends science and imagination; delivering multi-channel communications that are both compelling and...

Latest intelligence

A new reality for healthcare
When mobile phones came onto the mass market it would have been difficult to see how they were to develop into the ubiquitous multimedia devices they are now. Their power,...
Digital-green-grey.jpg
Are you getting these benefits from your digital technology?
Your organisation switched from ‘paper to glass’, buying the latest mobile devices and hiring digital agencies to fill them with eye-catching content. But what happened?...
Alzheimer's: the numbers we cannot forget
In this article, Consultant David Cooney explores the success rate of trials in AD and the reasons for this incredulous situation, as well as looking at the some of the...

Infographics